Become A Featured Company

Medical Marijuana’s Kannaway® Expands into Europe

Ryan Allway

May 11th, 2017

News, Top News

The cannabis industry is rapidly growing in North America and around the world, but the cannabidiol (CBD) segment of the market is largely underappreciated by investors. With 700% growth projected by 2020, the market for CBD-based products could exceed $2 billion to $3 billion over the next decade. Investors may want to consider adding companies with exposure to the rapidly growing subset of the cannabis industry.

In this article, we will take a look at Medical Marijuana Inc.’s (OTC Pink: MJNA) Kannaway® and its recent move into the European marketplace.

Rapidly Growing Market

The cannabis industry is expected to reach over $50 billion by 2026, according to Cowen & Co., but the market extends well beyond medical and recreational marijuana. The Hemp Business Journal projects that the market for non-psychoactive cannabidiol (CBD) will grow 700% to $2.1 billion by 2020 as consumers seek out its potential health benefits. Many CBD oils are already legal across all 50 states and offer several potential benefits to consumers.

CBD that is derived from hemp is legal to import and purchase in all 50 states without a prescription since cannabidiol isn’t listed in the Controlled Substances Act like THC and marijuana. This means that consumers don’t have to wait around for states to legalize its use, which has become the case for medical marijuana. The only problem is that quality control has been difficult to assess while medical claims have forced the FDA to take action in some cases.

Some analysts predict that the CBD market could be even larger than the Hemp Business Journal projects. For example, GreenWave Advisors’ Matt Karnes recently said, “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only [in cases where CBD is derived from marijuana plants] – this is in addition to the 28 states plus DC that have legalized medical marijuana.”

Direct Marketing Leader

Medical Marijuana Inc.’s Kannaway® is the first direct marketing company to offer cannabis products to consumers. The lifestyle brand is focused on nutrition and healthy choices with all-natural ingredients, CBD hemp oil, and a proprietary herbal blend in each product. Through its growing network of brand ambassadors, the multi-level marketing firm sells these products around the world in a way that benefits both consumers and small businesses.

The Kannaway brand helps solve a critical issue facing CBD products – trust. Many products on the market are cut with low-cost oils that have been imported from China, which have little to no actual CBD content. The FDA’s warning letters – such as the one mentioned above – are evidence of this lack of quality control. Kannaway is a worldwide brand that’s backed by the reputation of Medical Marijuana Inc.’s Real Scientific Hemp Oil (“RSHO”).

In 2014, Kannaway was awarded Start-up of the Year from the Academy of Multi-Level Marketing for its swift growth and supportive company structure. The company has since introduced new products and grown its ambassador program around the world with a focus on South American and, now, European markets. Consumers continue to embrace these products as evidence mounts supporting the efficacy of CBDs for health.

Expansion into Europe

Medical Marijuana Inc. recently announced the establishment of Kannaway® Europe, which is expected to be fully operational by the fourth quarter of this year. The new European segment will focus on attracting European brand ambassadors to further expand the company’s presence throughout the lucrative European marketplace. Many countries in the region are starting to relax their laws and follow the lead of North America.

As part of the expansion, the company appointed Jakub Duda as Operations Director of Kannaway Europe. Mr. Duda is a Poland-native that has worked with Kannaway CEO Blake Shroeder running two successful European businesses that each grossed more than $50 million per year. He brings tremendous experience to the table and will help advance the company’s mission of becoming a leading worldwide direct marketing leader.

“We are extremely excited to become the first direct selling company feature phyto-cannabinoid based products to have operations in Europe and to share our products, culture, and mission throughout Europe,” said Mr. Shroeder in the press release announcing the European venture. “Furthermore, Jakub is an incredible addition to our team and we are confident that his background and passion will help ensure that Kannaway Europe is a success.”

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) represents a compelling investment opportunity within the burgeoning cannabis industry. With Kannaway’s new European operations, the company hopes to expand its direct marketing business into new global markets. Investors also benefit from the company’s other holdings focused on the medical aspects of the industry, including its large stake in AXIM Biotech Inc. (OTCQB: AXIM).

For more information, visit the company’s website or CannabisFN’s company profile.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading